Please provide your email address to receive an email when new articles are posted on . The FDA approved pacemakers with automatic MRI field sensing functionality. This feature is designed to ...
CUPCOMP: A multi-site UK trial in carcinoma of unknown primary: A comparison across tissue and liquid biomarkers. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Beyond tumor-shed markers: AI driven tumor-educated polymorphonuclear granulocytes monitoring for multi-cancer early detection. Clinical outcomes of a prospective multicenter study evaluating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results